Reversing the Learning Disability of Down Syndrome 2018 Stanford Bio-X USRP Talks - Wednesday, August 22, 2018
USRP 2020 - Modulating p75 neurotrophin receptor signaling as a therapeutic strategy for Huntington’s disease